News

Glenmark Pharmaceuticals Inc. issued a recall for some of its Potassium Chloride Extended-Release Capsules over a "failed dissolution" that may cause heart attacks.
Sutab ® (sodium sulfate, magnesium sulfate, and potassium chloride tablets; Sebela Pharmaceuticals), an osmotic laxative, is now available for cleansing of the colon in preparation for ...
You can also take potassium chloride through an extended-release tablet, extended-release capsule, injectable, oral solution, and powder for oral solution. Before you start or stop taking the ...
Potassium Chloride Extended Release tablets USP, 10 mEq (750 mg) and 20 mEq (1500 mg) were approved by the USFDA for treating patients with Hypokalemia.
Potassium (as chloride) 10mEq, 20mEq. Hyperkalemia. Chronic renal disease. Acute dehydration. Heat cramps. Severe tissue destruction. Adrenal insufficiency. Familial periodic paralysis. Acidosis ...
"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Potassium Chloride Extended Release Tablets USP, 10mEq (750 mg) and 20mEq ...
Glenmark Pharmaceuticals has received final approval from the US health regulator for Potassium Chloride Extended Release Tablets, used for treating low levels of potassium in blood. “Glenmark ...
Glenmark Pharmaceuticals has received final approval from the US health regulator for Potassium Chloride Extended Release Tablets, ... AI-171 black box data extracted, analysis on.
The Food and Drug Administration approved Glenmark Pharamceuticals' potassium chloride tablets. The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced ...
The Food and Drug Administration approved Glenmark Pharamceuticals’ potassium chloride tablets. Advertisement. By: Mackenzie Bean. Friday, July 29th, 2016. Print Share.
Drug Involved in Errors: Potassium chloride, a salt available in a host of generic formulations, including solutions, tablets and injectible forms. Indication: Low potassium levels, often as a ...